Cheese curds recalled from Trader Joe's after sample tests show listeria
Manufacturer Face Rock Creamery's recall notice said the Oregon company did the testing itself on its Vampire Slayer Garlic Cheddar Curds. Listeria infects about 1,600 people in the United States each year, barely 1/100th of salmonella, but listeria kills about 260, according to the CDC.
This covers 6-ounce plastic cups with lot Nos. 20250519VS01 and 20250519VS02, and a Use By date of '08292025.'
Now, the relatively good news: The curds went only to Trader Joe's in Northern California, including Fresno, and Nevada cities Reno, Carson City and Sparks. If you have recalled curds, return them to the store for a refund or at least throw them deep into the garbage, then wash and sanitize any surface or utensil that touched them.
For questions, contact the company's Customer Care team through email at info@facerockcreamery.com. The best time is 11 a.m. to 8 p.m., Eastern.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
27 minutes ago
- Associated Press
Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / July 3, 2025 / RedChip Companies will air interviews with Fathom Holdings, Inc. (Nasdaq:FTHM) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, July 5, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S. Access the interviews in their entirety at: In an exclusive interview, Marco Fregenal, CEO of Fathom Holdings, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company's disruptive approach to real estate services through its proprietary, technology-driven platform. Fregenal highlights Fathom's flat-fee commission model, which empowers agents to retain more of their earnings while enabling industry-leading retention and rapid national expansion. With operations in 43 states and a network of over 14,700 agents, Fathom is scaling efficiently through its virtual model, integrated ancillary services, and strategic acquisitions, including the recent addition of My Home Group. He also addresses Fathom's innovative Bitcoin strategy and strong financial performance, including a 32% year-over-year revenue increase in Q1 2025, positioning the Company to capture additional market share amid an improving housing market. Pete O'Heeron, CEO of FibroBiologics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to spotlight the company's pioneering work in fibroblast-based cell therapies. O'Heeron discusses the advantages of fibroblasts over traditional stem cells, highlighting their regenerative and immunomodulatory properties, scalability, and safety profile. He outlines the Company's robust pipeline, led by CYWC628 for diabetic foot ulcers, which is slated to enter a Phase 1/2 clinical trial in Australia later this year. Additional programs, including CybroCell™ for degenerative disc disease and CYMS101 for multiple sclerosis, target multi-billion-dollar markets and are supported by promising preclinical and early human data. With over 240 issued and pending patents, a recently completed cGMP-compliant cell bank, and a seasoned leadership team, FibroBiologics is advancing a scalable, off-the-shelf platform poised to transform treatment for chronic diseases and deliver significant long-term value to shareholders. FTHM and FBLG are clients of RedChip Companies. Please read our full disclosure at About Fathom Holdings Inc. Fathom Holdings Inc. is a national, technology-driven real estate services platform integrating residential brokerage, mortgage, title, and SaaS offerings to brokerages and agents by leveraging its proprietary cloud-based software, intelliAgent. The Company's brands include Fathom Realty, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. For more information, visit About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit About RedChip Companies RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights. To learn more about RedChip's products and services, please visit: 'Discovering Tomorrow's Blue Chips Today"™ Follow RedChip on LinkedIn: Follow RedChip on Facebook: Follow RedChip on Instagram: Follow RedChip on Twitter: Follow RedChip on YouTube: Follow RedChip on Rumble: Subscribe to our Mailing List: Contact: Dave Gentry RedChip Companies Inc. 1-407-644-4256 [email protected] --END-- SOURCE: RedChip Companies, Inc. (Media Suite) press release
Time Business News
an hour ago
- Time Business News
Tantric Massage in Seattle for Energy and Emotional Healing
In the heart of Seattle's progressive wellness landscape, more individuals are turning toward ancient, holistic practices to find emotional clarity and inner peace. Among them, Tantric massage stands out as a deeply sensual and spiritually nourishing modality. This is not just about touch, it is about awakening the body's natural intelligence, restoring energy flow, and releasing emotional blockages stored in the physical form. For those navigating stress, disconnection, or emotional fatigue, Tantric massage in Seattle offers a powerful path to healing that blends sensual awareness with energetic realignment. At its essence, Tantric massage is a sacred bodywork practice rooted in ancient Eastern traditions. Unlike conventional massage therapies, it combines breath, movement, conscious touch, and sensual presence to awaken life force energy—often referred to as prana or kundalini. Tantric massage is designed not only to relax muscles but to restore harmony between body and spirit, creating a sense of emotional renewal and energetic clarity. Modern life often disconnects us from our feelings. Emotional stress, suppressed desires, and unresolved trauma can manifest as physical tension, fatigue, or anxiety. Tantric massage provides a safe, supportive environment to explore and release these emotional patterns. Encourages emotional release through intentional, nurturing touch through intentional, nurturing touch Restores self-acceptance by reconnecting with the body in a non-judgmental way by reconnecting with the body in a non-judgmental way Promotes vulnerability and trust in a safe, consensual setting in a safe, consensual setting Reduces anxiety and overthinking by grounding awareness in sensation This type of work allows emotions that may have been stored in the body for years to be gently acknowledged, expressed, and released. In Tantric traditions, it is believed that the body holds various energy centers known as chakras. Emotional wounds and daily stress can block the natural flow of this energy, leading to imbalance and fatigue. Unblocks stagnant energy in key areas like the heart, solar plexus, and sacral chakras in key areas like the heart, solar plexus, and sacral chakras Revitalizes your energetic flow through deep breath and guided touch through deep breath and guided touch Enhances sensual awareness , which is essential for vitality and joy , which is essential for vitality and joy Aligns physical and emotional energy, leading to greater clarity and centeredness By moving slowly and intentionally, the practitioner invites the body to return to its natural rhythm calm, centered, and alive. Seattle's vibrant wellness scene and open-minded community create the ideal environment for Tantric massage to flourish. The city's spirit of exploration and spiritual depth allows individuals to embrace alternative forms of healing with curiosity and respect. You'll find that practitioners in Seattle are: Trauma-informed and spiritually aware Trained in combining sensual energy work with therapeutic care with therapeutic care Focused on providing consensual, safe, and respectful experiences experiences Equipped to help you navigate physical and emotional boundaries with care This level of professionalism and integrity makes Seattle one of the most trusted destinations for Tantric healing in the United States. Every session is personalized. The goal is not to achieve a specific outcome but to stay fully present with your body, breath, and feelings. Guided breathwork to relax the nervous system Conscious, slow touch with clear intention Attention to areas where energy feels blocked or dull Emotional support to process anything that arises during the experience There is no rush. The session moves at your pace and with your full consent. This approach creates a safe space for deep sensual and emotional awakening. You may benefit from this practice if you: Feel emotionally numb or disconnected from your body Are recovering from heartbreak, loss, or trauma Seek a more conscious relationship with your sensual energy Are curious about how touch can support spiritual growth Tantric massage is not only for those seeking intimacy—it's for anyone ready to reconnect with their life force and experience healing on a whole new level. In a world that often demands more than it gives, finding a healing path that honors both your emotional needs and your sensual nature is invaluable. Tantric massage in Seattle is more than bodywork it is a sacred invitation to come home to yourself. Through breath, intention, and deeply respectful touch, this practice dissolves tension, awakens the senses, and gently guides you toward emotional and energetic balance. If you're ready to explore the healing power of presence, start your journey today—one breath, one moment, one sensual awakening at a time. TIME BUSINESS NEWS
The Verge
an hour ago
- The Verge
RFK Jr.'s plan to put ‘AI' in everything is a disaster
In a 92-minute interview with Tucker Carlson on Monday, RFK Jr. drilled down on his vision for the US Department of Health and Human Services (HHS). Artificial intelligence — arguably, a uselessly vague umbrella term — came up multiple times. (As did conspiracy theories and disinformation on vaccines and autism, the medical establishment, and covid-19 deaths.) As the head of HHS, Kennedy said his federal department is undergoing an 'AI revolution.' He implored viewers to 'stop trusting the experts,' as highlighted by Gizmodo, and, presumably, put their trust into AI instead of decades of scientific consensus. He referenced that AI tools were being used to 'detect waste, abuse, and fraud' across the federal government — the tagline for Elon Musk's misguided and disastrous DOGE initiative that's already led to a scramble to rehire hundreds of wrongfully cut CDC employees. Kennedy also vaguely declared that the CDC will be using AI to 'look at the mega data that we have and be able to make really good decisions about interventions,' demonstrating how flimsy his grasp of AI is. Kennedy said that AI will rapidly accelerate the drug approval process at the FDA, implying it will fully replace animal testing. This is not entirely new, echoing an April announcement from Kennedy's Food and Drug Administration that the agency will be phasing out animal testing for some pharmaceuticals in favor of 'AI-based computational models' and other countries' safety data. That agency-level change followed the 2022 passage the FDA Modernization Act 2.0 under President Joe Biden, which repealed requirements for all new drugs to undergo animal testing. There is a lot of ongoing research into the potential for alternate approaches like organ-on-chip systems, organoid cultures, and AI models to supplement or reduce the amount of animal testing used in drug development. And computer modeling has long been a part of pharmaceutical evaluation. However, it's likely premature to claim that AI can wholly eliminate the need for animal models. 'There is currently no full replacement for animal models in biomedical research and drug development,' wrote the National Association for Biomedical Research in an April statement. Even more concerning were Kennedy's hints that the current Vaccine Adverse Event Reporting System (VAERS), which is overseen by the CDC, is set to be overhauled and outfitted with AI. (He previously suggested automating the system in April.) VAERS is a first-line detection system for catching rare, previously undetected risks associated with vaccines that has often been misrepresented by anti-vaccine advocates. AI drug testing may sound unsettling, but it would be conducted by external researchers and drug makers. Pharmaceutical companies are incentivized to not release dangerous products because they lose money when they harm people; Kennedy wouldn't be so directly held to account. Misinterpretation of VAERS data at the institutional level could sow further distrust in public health and give Kennedy's newly appointed vaccine advisory committee ammunition to change vaccine recommendations, legitimize their fringe beliefs, and limit vaccine access. Anyone can report to VAERS (and certain providers are required to report) anytime a person experiences any negative health event in the aftermath of a vaccination. A report to VAERS does not indicate causality. 'There's nothing about VAERS that allows us to determine whether a vaccine caused the reported adverse event,' says Kawsar Talaat, an infectious disease physician and vaccine safety researcher at Johns Hopkins University. 'People report things like anger after vaccination,' she says, for which there's no biologically plausible mechanism relating back to immunization. Even more serious events, like death following a vaccination, overwhelmingly bear out to be unrelated to the shot itself. 'The thing about vaccines is they protect against preventable diseases, not everything else that occurs in life,' says Paul Offit, a vaccine scientist, virologist, and professor of pediatrics at the Children's Hospital of Philadelphia. Yet even so, VAERS reports are followed up with CDC investigation through complementary programs like Vaccine Safety Datalink and the Clinical Immunization Safety Assessment Project. The system has worked since its establishment in 1986 to generate hypotheses for potential vaccine side effects and even to detect very rare vaccine risks. For instance, VAERS did successfully pick up the myocarditis associated with mRNA covid-19 vaccines, which only showed up in about one per 30,000 doses, and the blood clotting associated with the Johnson & Johnson covid-19 shot, which affected about one in 250,000 people, Offit notes. 'You're not going to pick that up pre-licensure, so I think VAERS works well,' he says. 'The problem is that anti-vaccine activists use it to mean that anything reported in that system is a real issue, which is obviously wrong,' he adds — echoing Talaat's point that anyone can report anything. It's not clear how Kennedy plans to introduce AI into VAERS, but presumably he means to feed VAERS data into some sort of automated system for identifying alleged vaccine side effects and risks. Earlier this year, the top US vaccine regulator at the FDA was forced out over his refusal to grant Kennedy unfettered access to the VAERS database, out of fears he and his appointees would manipulate the data. Now, with little standing in his way, Kennedy seems poised to do just that. There is a reasonable argument to be made that the right set of machine learning algorithms or AI tools could streamline the review process for VAERS claims. But AI systems are only as good as their training and parameters. If you feed them faulty information, that's what they're going to regurgitate. If you build an AI system to validate your preexisting belief that vaccines are dangerous, that's exactly what it will do. Despite the genuine promise that some AI approaches have in health policy and medicine, experts routinely emphasize that we need to tread carefully in building, vetting, and adopting these technologies. Bias, privacy concerns, legal challenges, and user manipulation all remain major issues, according to one 2024 review of 120 studies of generative AI in medicine. (Not to mention hallucinations: In May, the 'Make America Healthy Again Commission,' a presidential advisory committee chaired by Kennedy, released a likely AI-generated report containing false citations to studies that did not exist.) The key question here is if an AI vaccine risk-assessment system could be developed fairly and accurately under Kennedy's leadership. Offit, at least, doesn't think so. 'Robert F. Kennedy Jr. is an anti-vaccine activist, a science denialist, and a conspiracy theorist,' he says. 'He will do everything he can, as long as he is in this position, to make vaccines less available, less affordable, and more feared.'
